Drug maker GlaxoSmithKline PLC said Wednesday it would lay off hundreds of its U.S. workers to reduce costs and to streamline its research and drug-marketing operations by the end of 2015.. The layoffs, which focus on the company’s North Carolina site, are the latest of many job cuts in the pharmaceutical sector in recent years, driven by patent expirations for big-selling drugs and efforts to outsource more research and development. A GlaxoSmithKline spokeswoman attributed the company’s moves to “market changes, evolving customer...
  